Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-08-22

Clinical Trial Update: Askina Calgitrol Paste Burns [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of Askina Calgitrol Paste for treating third-degree burns has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Askina Calgitrol Paste (calcium alginate paste)

Snippet

Sponsor: BBraun Medical SAS | Conditions: Third Degree Burns | Phase 3 | Status: WITHDRAWN